Exact Sciences
EXAS
#1783
Rank
C$12.95 B
Marketcap
$70.01
Share price
-2.28%
Change (1 day)
-14.40%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$4.93 Billion

According to Exact Sciences's latest financial reports the company's total liabilities are C$4.93 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$4.41 B2.11%
2022-12-31C$4.32 B2.81%
2021-12-31C$4.20 B22.53%
2020-12-31C$3.42 B115.63%
2019-12-31C$1.59 B38.48%
2018-12-31C$1.14 B1068.97%
2017-12-31C$98.24 M75.13%
2016-12-31C$56.09 M8.79%
2015-12-31C$51.56 M86.4%
2014-12-31C$27.66 M129.77%
2013-12-31C$12.04 M-10.47%
2012-12-31C$13.44 M-1.76%
2011-12-31C$13.68 M-18.29%
2010-12-31C$16.75 M-19.07%
2009-12-31C$20.7 M104.38%
2008-12-31C$10.12 M22.23%
2007-12-31C$8.28 M-20.12%
2006-12-31C$10.37 M-32.62%
2005-12-31C$15.39 M-29.29%
2004-12-31C$21.77 M-25.24%
2003-12-31C$29.12 M57.12%
2002-12-31C$18.53 M181.55%
2001-12-31C$6.58 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$0.48 B-90.26%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.13 B-97.20%๐Ÿ‡บ๐Ÿ‡ธ USA
C$30.44 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
C$84.92 B 1,619.69%๐Ÿ‡ซ๐Ÿ‡ท France